Table 1 Patient characteristics
Characteristics | Total (n = 304) |
|---|---|
Age (years: median [range]) | 71 [22–93] |
Gender | Â |
Male | 252 (83%) |
Female | 52 (17%) |
Histological subtype | Â |
Squamous cell carcinoma | 135 (44%) |
Adenocarcinoma | 149 (49%) |
Large cell carcinoma | 7 (2%) |
Not otherwise specified | 13 (4%) |
T stage | Â |
0 | 1 (0%) |
1 | 93 (31%) |
2 | 96 (32%) |
3 | 49 (16%) |
4 | 55 (18%) |
N stage | Â |
0 | 110 (36%) |
1 | 37 (12%) |
2 | 103 (34%) |
3 | 47 (15%) |
M stage | Â |
0 | 253 (83%) |
1 | 42 (14%) |
Clinical stage | Â |
I | 83 (27%) |
II | 25 (8%) |
III | 146 (48%) |
IV | 41 (13%) |
Chemotherapy status | Â |
Yes | 140 (46%) |
No | 164 (54%) |
Survival time (days: median [range]) | 598 [1–3364] |
Survival status | Â |
Survival | 126 (41%) |
Death | 178 (59%) |